ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $6,852,000 | +104.6% | 147,888 | +7.6% | 0.01% | +100.0% |
Q1 2019 | $3,349,000 | +68.4% | 137,379 | -1.5% | 0.00% | +33.3% |
Q4 2018 | $1,989,000 | -1.0% | 139,511 | +5.5% | 0.00% | +50.0% |
Q3 2018 | $2,010,000 | -20.4% | 132,248 | -12.0% | 0.00% | -33.3% |
Q2 2018 | $2,524,000 | +4.8% | 150,358 | +1.9% | 0.00% | 0.0% |
Q1 2018 | $2,408,000 | +24.4% | 147,550 | -2.4% | 0.00% | +50.0% |
Q4 2017 | $1,936,000 | +20.0% | 151,241 | +15.4% | 0.00% | 0.0% |
Q3 2017 | $1,613,000 | +45.1% | 131,051 | -1.4% | 0.00% | +100.0% |
Q2 2017 | $1,112,000 | -3.2% | 132,865 | +3.3% | 0.00% | 0.0% |
Q1 2017 | $1,149,000 | +15.5% | 128,578 | +13.6% | 0.00% | 0.0% |
Q4 2016 | $995,000 | +44.2% | 113,210 | +10.7% | 0.00% | 0.0% |
Q3 2016 | $690,000 | +89.6% | 102,309 | +0.0% | 0.00% | 0.0% |
Q2 2016 | $364,000 | +32.4% | 102,272 | +8.0% | 0.00% | – |
Q1 2016 | $275,000 | -29.8% | 94,723 | +2.0% | 0.00% | – |
Q4 2015 | $392,000 | -6.4% | 92,891 | +1.1% | 0.00% | – |
Q3 2015 | $419,000 | -34.9% | 91,895 | +2.8% | 0.00% | -100.0% |
Q2 2015 | $644,000 | -1.7% | 89,368 | +0.6% | 0.00% | 0.0% |
Q1 2015 | $655,000 | +66.2% | 88,864 | +6.6% | 0.00% | 0.0% |
Q4 2014 | $394,000 | +32.7% | 83,366 | -0.0% | 0.00% | – |
Q3 2014 | $297,000 | -21.8% | 83,395 | +0.3% | 0.00% | -100.0% |
Q2 2014 | $380,000 | -14.2% | 83,149 | -11.8% | 0.00% | 0.0% |
Q1 2014 | $443,000 | -1.8% | 94,259 | +4.7% | 0.00% | 0.0% |
Q4 2013 | $451,000 | -15.9% | 90,036 | +4.3% | 0.00% | 0.0% |
Q3 2013 | $536,000 | +36.7% | 86,296 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $392,000 | – | 86,296 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MUFG Americas Holdings Corp | 36,200 | $71,000 | 0.00% |